product summary
Loading...
company name :
MedChem Express LLC
product type :
protein
product name :
IdeS Protein, Streptococcus pyogenes (His, solution)
catalog :
HY-P74867
quantity :
5 μg;10 μg;50 μg
price :
67;115;320 USD
more info or order :
product information
Catalog Number :
HY-P74867
Product Name :
IdeS Protein, Streptococcus pyogenes (His, solution)
Product Type :
proteins
Host Species :
E. coli
Size :
5 μg;10 μg;50 μg
List Price :
67;115;320 USD
Product Description :
IdeS Protein is a highly specific IgG endopeptidase evolved from Streptococcus pyogenes, which can degrade IgG and participate in the immune response.IdeS Protein inhibits the function of certain neutrophil effectors, namely the production of reactive oxygen species (ROS), independently of IgG endopeptidase activity. IdeS Protein, Streptococcus pyogenes (His, solution) is the recombinant IdeS protein, expressed by E.coli , with N-10*His labeled tag.
SpeciesSummary :
Others
Background :
IdeS is a highly specific IgG endopeptidase evolved from Streptococcus pyogenes, which can not only degrade IgG but also directly or indirectly inhibit the innate immune response, thus promoting the survival of streptococcus in the inflammatory environment. IdeS was found to be identical to Mac-1 in Streptococcus, a protein thought to inhibit phagocytosis by inhibiting the recognition of IgG and/or complement configurations by the Fc receptor (CD16). IdeS/Mac-1 can inhibit the function of certain neutrophil effectors, namely the production of reactive oxygen species (ROS), independently of IgG endopeptidase activity [1] [2] .
ALTnames :
Immunoglubulin-degrading enzyme; ideS
Purity :
Greater than 95% as determined by reducing SDS-PAGE.
Buffer :
Supplied as a 0.22 μm filtered solution of PBS, 50 % Glycerol, pH 6.6.
Storage :
Shipping with dry ice
more info or order :
company information

MedChem Express LLC
18 Wilkinson Way, Princeton, NJ 08540
sales@medchemexpress.com
http://www.medchemexpress.com609-228-6898
headquarters: USA
browse more products
questions and comments